BTIG Reiterates Buy Rating on Solventum (SOLV)
BTIG analyst Ryan Zimmerman reiterated a Buy rating and $100.00 price target on Solventum (NYSE: SOLV).The analyst comments "We wanted ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
